BioNexus Gene Lab Corp (BGLC)
NASDAQ:BGLC
US Market

BioNexus Gene Lab Corp (BGLC) Cash flow

50 Followers

BioNexus Gene Lab Corp Cash Flow

BGLC's free cash flow for Q was $-208.69K. For the fiscal year, BGLC's free cash flow was decreased by $-2.11M and operating cash flow was $-34.44K. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -1.07M$ -1.30M$ 544.03K$ 9.16K$ 552.68K$ -217.27K
Investing Cash Flow
$ -344.73K$ -382.58K$ -450.50K$ -490.57K$ 1.32M$ -12.82K
Financing Cash Flow
$ 5.77M$ 5.75M$ 115.96K$ -28.22K$ -4.95K$ -180.81K
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 22.66M$ 5.93M$ 2.12M$ 2.12M$ 2.79M$ 859.08K
Income Tax Paid Supplemental Data
$ 33.29K$ -66.97K$ -170.45K$ -226.77K$ 143.50K$ 10.71K
Interest Paid Supplemental Data
$ 5.08K$ 13.93K$ -12.48K$ -12.97K$ 11.31K$ 5.05K
Issuance Of Capital Stock
------
Issuance Of Debt
---$ -1.92K--
Repayment Of Debt
---$ -1.92K$ -4.95K$ -16.78K
Free Cash Flow
$ -1.40M$ -1.62M$ 489.86K$ 9.16K$ 131.06K$ -230.09K
Domestic Sales
------
Foreign Sales
------
Currency in USD

BioNexus Gene Lab Corp Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis